Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$218,328,147
+$11,628,915 QoQ
Shares Held
867,621
-8.7% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
1.90%
of 13F equity value
Holder Rank
#146
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026B. Metzler seel. Sohn & Co. AG holds $558,946,966 across 9 Drug Manufacturers - General names. ABBV ranks #1 (39.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
867,621 | $218,328,147 | |
| 2 | LLY |
ELI LILLY & Co
|
128,222 | $153,793,325 | |
| 3 | JNJ |
Johnson & Johnson
|
310,590 | $78,880,542 | |
| 4 | MRK |
Merck & Co., Inc.
|
443,208 | $56,952,227 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
114,360 | $14,448,242 | |
| 6 | AMGN |
Amgen Inc
|
39,041 | $14,137,526 | |
| 7 | PFE |
Pfizer Inc
|
576,524 | $13,882,696 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
101,975 | $5,875,798 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218,328,147 | 867,621 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $206,699,232 | 950,385 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $190,486,856 | 833,677 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $115,450,936 | 498,622 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $87,374,303 | 470,716 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $101,574,667 | 484,797 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $77,393,857 | 435,531 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $89,420,326 | 452,807 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $84,150,970 | 490,619 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $83,166,161 | 456,706 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $59,270,600 | 382,465 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $52,749,650 | 353,882 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $46,672,088 | 346,412 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $51,615,002 | 323,869 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $62,681,246 | 387,855 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $47,275,606 | 352,251 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $55,255,379 | 360,769 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $57,051,696 | 351,932 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $36,981,936 | 273,131 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||